{"id":"W2993755223","doi":"10.1158/1535-7163.targ-19-b049","title":"Abstract B049: Hyperprogressive disease after two cycles of immunotherapy in HER-2 positive metastatic gastric cancer","year":2019,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Pembrolizumab; Medicine; Nivolumab; Cancer; Immunotherapy; Response Evaluation Criteria in Solid Tumors; Internal medicine; Oncology; Regimen; Immunohistochemistry; Stomach; Gastroenterology; Disease; Progressive disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001371231,0.0003362146,0.0004386824,0.0004399467,0.0006920277,0.000382305,0.000286303,0.0009957113,0.001380649],"category_scores_gemma":[0.0003543132,0.000155289,0.0003819074,0.0002489601,0.0002883878,0.0002515583,0.0002490684,0.0008393311,0.0003454091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006440713,"about_ca_system_score_gemma":0.0002665081,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001873841,"about_ca_topic_score_gemma":0.002755957,"domain_scores_codex":[0.9999022,0.00001126576,0.000009382355,0.00003064531,0.00001414093,0.00003222643],"domain_scores_gemma":[0.9997842,0.00003672644,0.00003866498,0.00001272997,0.00001969952,0.0001081351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.001373382,0.0003527387,0.1260832,0.0001499228,0.00005409283,0.8361621,0.0003906428,0.0003922525,0.01643733,0.0001962414,0.002507768,0.01590039],"study_design_scores_gemma":[0.0001077619,0.002190826,0.239537,0.00004558613,0.00008135322,0.7472914,0.0002883776,0.002151343,0.004119243,0.0002505287,0.003908539,0.00002801217],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944057,0.001103683,0.0003190709,0.0009052059,0.0000486769,0.00006466198,0.0003207031,0.00003959348,0.002792676],"genre_scores_gemma":[0.9979621,0.000224755,0.0002324739,0.0003622877,0.00004233866,0.00001102812,0.0002373221,0.00000597292,0.0009217751],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001873841,"threshold_uncertainty_score":0.004673123,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009132067387983691,"score_gpt":0.2866584744196884,"score_spread":0.2775264070317048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}